Sign in
Not yet recruitingNo phase

Modified Inhaled Nitric Oxide in Ventilated Patients With Acute Respiratory Failure

Key facts

Who runs it
Southeast University, China
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
People taking part
424 people, planned
Started
1 Nov 2026
Expected to end
20 Feb 2029
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Modified iNO
Record updated
27 October 2026

Who can take part

Age
18 years to 90 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (11)Hide the full registry criteria

Who can take part

  • Age ≥ 18 years
  • Acute respiratory failure (PaO₂/FiO₂ ratio < 300 mmHg)
  • Endotracheal intubation due to pneumonia
  • Duration of mechanical ventilation ≤ 72 h

Who cannot take part

  • Patients who received iNO or ECMO prior to enrollment
  • Severe chronic respiratory disease requiring long-term home oxygen therapy or noninvasive ventilation
  • History of pulmonary malignancy, pneumonectomy, or lung transplantation
  • Expected duration of mechanical ventilation < 48 h
  • Severe other organs dysfunction with a low expected survival (7 days) or palliative care
  • Pregnancy or lactation
  • Refusal to sign the informed consent

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Acute respiratory failure or nitric oxide or pneumonia

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

Pneumonia is the main cause of ICU admission in patients with acute respiratory failure (ARF). Severe pneumonia is a serious lung infection caused by bacteria, fungi, viruses, and other pathogens. It often leads to respiratory failure requiring mechanical ventilation. It is also accompanied by septic shock or multiple organ dysfunction, and patients need intensive care. The average mortality rate is 30%-40%. Therefore, there is an urgent need to find treatments that improve outcomes in patients with severe pneumonia. Inhaled nitric oxide (iNO) can selectively dilate pulmonary vessels in well-ventilated lung areas. This reduces pulmonary artery pressure, improves the ventilation/perfusion ratio, and increases oxygenation. At 80 ppm, iNO can effectively reduce mean pulmonary artery pressure and pulmonary vascular resistance. It also reduces oxidative stress and has anti-inflammatory effects. Short-term inhalation is safe. The level of positive end-expiratory pressure (PEEP) affects the effect of NO. Setting PEEP according to airway opening pressure (AOP) can deliver iNO efficiently to target areas. Based on this, the study team designed this randomized controlled trial to investigate whether a modified iNO regimen, PEEP set according to AOP combined with 80 ppm NO, improves outcomes in patients with acute respiratory failure receiving mechanical ventilation.

The 2 groups in the trial

  • Modified iNO groupTreatment being tested

    Patients will receive PEEP set according to AOP and undergo an iNO trial with an initial concentration of 80 ppm and subsequent stepwise reduction.

    Treatment: Modified iNO

  • Low PEEP-FiO2 table groupNo study treatment, for comparison

    PEEP will be set according to the low FiO2-PEEP table.

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effect of a Modified Inhaled Nitric Oxide Regimen on Outcomes in Patients With Acute Respiratory Failure Receiving Mechanical Ventilation: A Prospective, Multicenter, Open-Label, Randomized Controlled Trial
Criteria questions
Built from NCT07892001, who can take part
Record updated
27 October 2026